Theravance Biopharma, Inc. today announced that new preliminary data from the ongoing Telavancin Observational Use Registry (TOUR™) study are the focus of three poster presentations at the 27th European...

People who have recently been found to have drug-resistant bacteria in their urine or stool samples have a greatly increased risk of developing a bloodstream infection that is also resistant to certain...

A study that evaluated an investigational dosage of once-daily ledipasvir 45 mg/sofosbuvir 200 mg (LDV/SOF) in children aged six to 11 years infected with the Hepatitis C virus (HCV), found that 99% of...

Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature’s...

The Centers for Disease Control and Prevention (CDC) released a health advisory Tuesday describing the identification of emerging Shigella strains with elevated minimum inhibitory concentration values...

Viruses that specifically kill bacteria, called bacteriophages, might one day help solve the growing problem of bacterial infections that are resistant to antibiotic treatment. Researchers at Baylor College...

WHO reports remarkable achievements in tackling neglected tropical diseases (NTDs) since 2007. An estimated 1 billion people received treatment in 2015 alone. “WHO has observed record-breaking progress...

Recognized for easing psoriasis symptoms of dry, itchy, flaky skin, five products have recently been awarded the National Psoriasis Foundation (NPF) Seal of Recognition. The NPF Seal of Recognition highlights...

Commonly used sedatives called benzodiazepines are associated with an increased risk of pneumonia when used in people with Alzheimer disease, according to a study published in CMAJ (Canadian Medical Association...

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17....